UPPSALA, Sweden, Jan. 2, 2017 /PRNewswire/ -- As from today, Biotage AB (BIOT.ST) change segment at Nasdaq OMX Nordic, from the Small Cap Segment to the Mid Cap Segment.
Contact persons:
Torben Jörgensen, CEO
Tel: +46 707 490584, torben.jorgensen@biotage.com
Erika Söderberg-Johnson, CFO
Tel: +46 707 204820, erika.soderberg.johnson@biotage.com
About Biotage
Biotage offers efficient separation technologies from analysis to industrial scale and high quality solutions for analytical chemistry from research to commercial analysis laboratories. Biotage's products are used by government authorities, academic institutions, pharmaceutical and food companies, among others. The company is headquartered in Uppsala and has offices in the US, UK, China, Japan and South Korea. Biotage has approx. 320 employees and had sales of 611 MSEK in 2015. Biotage is listed on the NASDAQ OMX Nordic stock exchange. Website: http://www.biotage.com/
CONTACT:
This information was brought to you by Cision http://news.cision.com
http://news.cision.com/biotage/r/biotage-s-shares-now-traded-on-the-mid-cap-segment-of-nasdaq-omx-nordic,c2159052
The following files are available for download:
http://mb.cision.com/Main/705/2159052/609771.pdf | Press release (PDF) |
